One challenge for innovators at MSK and elsewhere is that technology development is costly and funding options are limited—especially once the potential for federal grant funding has been exhausted.
Chiltern Vital Group (CVG) and Cambridge Atomworks are pleased to announce the signing of a letter of intent to facilitate research and development into Cambridge Atomworks’ ODIN nuclear micro-reactor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results